Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence

Journal of Endourology
Peter TsakirisChristian Chaussy

Abstract

Developments in the technology applied to the field of minimally invasive surgery have led to the exploration of high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer. Extensive research and continuous evolution have resulted in two commercially available HIFU devices: the Ablatherm and the Sonablate500. These devices are conceptually the same; however, specific technical differences exist. This paper reviews the clinical outcomes obtained with these devices, evaluates the quality of the evidence from the individual trials, and provides the results of a head-to-head comparison in terms of oncologic outcomes and complication rates.

References

Dec 1, 1973·Archives of Surgery·C A LinkeC W Fridd
Jan 1, 1994·Ultrasound in Medicine & Biology·S B BarnettJ Bang
Apr 1, 1999·European Journal of Ultrasound : Official Journal of the European Federation of Societies for Ultrasound in Medicine and Biology·J Y ChapelonA Gelet
Sep 29, 2004·Prostate Cancer and Prostatic Diseases·M Colombel, A Gelet
Aug 2, 2005·Journal of Endourology·Xavier RebillardGuy Vallancien
Dec 13, 2005·BJU International·Toyoaki UchidaAkira Irie
Apr 29, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Toyoaki UchidaTakefumi Satoh
May 13, 2006·Nihon rinsho. Japanese journal of clinical medicine·Akira Ishikawa, Tadaichi Kitamura
Jul 22, 2006·European Urology·Laura PoissonnierAlbert Gelet
Feb 7, 2007·Expert Review of Medical Devices·Rowland Illing, Mark Emberton

❮ Previous
Next ❯

Citations

Apr 17, 2013·Abdominal Imaging·Fergus V CoakleyAaron B Caughey
Oct 15, 2008·Prostate Cancer and Prostatic Diseases·V ChalasaniJ Chin
Apr 7, 2010·Journal of Endourology·Christian G Chaussy, Stefan Thüroff
Oct 12, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·H LukkaUNKNOWN Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care
Apr 10, 2010·European Urology·Scott EggenerSimon Brewster
Aug 14, 2008·Anaesthesia·C-L YaoM G Irwin
Jun 8, 2012·BJU International·Ernesto R CordeiroJean J M C H de la Rosette
May 18, 2013·Journal of Magnetic Resonance Imaging : JMRI·Stephanie T ChangFergus V Coakley
Feb 16, 2010·The Urologic Clinics of North America·Kyle O RoveE David Crawford
May 6, 2015·Journal of Endourology·Michael Cookson, Kelly Stratton
Mar 27, 2015·International Journal of Colorectal Disease·Deborah S KellerMaher A Abbas
Jan 26, 2010·Current Opinion in Urology·Osamu Ukimura
Aug 22, 2012·Expert Review of Medical Devices·Petros SountoulidesEnrico Finazzi-Agró

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.